经尿道双极等离子体汽化电切术治疗高龄高危前列腺增生症

Transurethal plasmakentic vaporization of prostate for treatment of senior and high risk BPH patients

目的探讨经尿道双极等离子体汽化电切术治疗高龄高危前列腺增生症(BPH)的安全性和有效性。方法回顾性分析经尿道双极等离子体汽化电切术治疗高龄高危前列腺增生症57例的临床资料。结果该组57例高龄高危前列腺增生症患者安全度过围手术期,手术时间30～110min,平均(48.60±17.7)min;切除前列腺组织22～65g,平均(40.05±5.22)g;术中失血80～200mL,平均(140±24.75)mL。国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)及残余尿(RUV)与术前相比有明显改善,差异有统计学意义(P<0.05)。结论经尿道双极等离子体汽化电切术是当前最适合治疗高龄高危BPH患者的手术方式之一。

Objective To investigate the safety and efficacy of transurethral plasmakentic vaporization of prostate （TUPKVP） for treatment of senior and high risk benign prostatic hyperplasia （BPH）.MethodsThe clinical data of 57 patients with senior and high risk BPH treated with TUPKVP was reviewed.ResultsAll patients were safe during the perioperative period. The mean operative time was （48.60 ± 17.7） min （ranged from 30 min to 110 min）; the resected BHP tissue weighted （40.05 ± 5.22） g （ranged from 22 g to 65 g）; the volume of intraoperative bleeding was （140 ± 24.75） mL （ranged from 80～200 mL）. IPSS, QOL, Qmax and RUV improved significantly compared with preoperation （P 0.05）.ConclusionTUPKVP is the one of most suitable treatment for senior and high risk BPH.